focalinterest.com

AI Summary of Peer-Reviewed Research

This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. [See full disclosure ↓]

Publishing process signals: STANDARD — reflects the venue and review process. — venue and review process.

Low-dose aspirin is recommended to prevent preeclampsia in high-risk pregnancy

—

in
A healthcare professional in a white coat holding a tablet sits facing a pregnant woman in a light blue shirt during a medical consultation in a clinical setting.
Research area:MedicineObstetrics and GynecologyPregnancy and preeclampsia studies

What the study found

Low-dose aspirin (LDA), a small daily dose of aspirin, is widely studied in pregnancy and is recommended for preventing preeclampsia, a pregnancy complication involving high blood pressure. The abstract says it has strong evidence for reducing maternal and perinatal morbidity, especially when started before 16 weeks of pregnancy.

Why the authors say this matters

The authors say hypertensive disorders of pregnancy are major contributors to maternal and perinatal illness and death worldwide, and the findings indicate that LDA has an important role in high-risk pregnancies. The study suggests additional benefits for selected cases and notes that major guidelines support LDA use.

What the researchers tested

The article reviews aspirin history and its clinical applications in pregnancy, with emphasis on low-dose aspirin. It describes aspirin’s mechanism as irreversible inhibition of COX-1, which reduces thromboxane A2 and produces sustained antiplatelet effects.

What worked and what didn't

The abstract reports that LDA is associated with reduced maternal and perinatal morbidity, particularly when started before 16 weeks. It also says additional benefits include lower rates of preterm birth, improved foetal growth in selected cases of IUGR (intrauterine growth restriction), and improved pregnancy outcomes in women with APS (antiphospholipid syndrome) and SLE (systemic lupus erythematosus) when used alone or with heparin.

What to keep in mind

The abstract does not describe study limitations in detail. It also limits some benefits to selected cases or high-risk pregnancies, and it does not provide specific effect sizes in the available summary.

Key points

  • Low-dose aspirin is recommended for preventing preeclampsia in pregnancy.
  • The abstract says benefits are strongest when aspirin is started before 16 weeks.
  • Reported additional benefits include lower preterm birth rates and improved foetal growth in selected cases of IUGR.
  • The abstract says pregnancy outcomes may improve in women with APS and SLE, with or without heparin.
  • Major guidelines named in the abstract support low-dose aspirin use in high-risk pregnancies.

Disclosure

Research title:
Low-dose aspirin is recommended to prevent preeclampsia in high-risk pregnancy
Publication date:
2026-02-25
DOI:
10.18203/2320-1770.ijrcog20260588
OpenAlex record:
View
AI provenance: AI provenance information is not available for this post.